News

Filter

176 to 185 of 468 results

TAC puts pressure on Janssen finalize development of TB drug bedaquiline

21-11-2013

The current standard of care for multi-drug resistant tuberculosis (MDR-TB) consists of poorly tested…

Antibiotics and Infectious diseasesbedaquilineJanssenJohnson & JohnsonPharmaceuticalPoliticsResearchRest of the World

AbbVie releases positive Phase III results for oral hepatitis C program

AbbVie releases positive Phase III results for oral hepatitis C program

18-11-2013

US drugmaker AbbVie has released the first Phase III results for the investigational three direct-acting-antiviral…

AbbVieAntibiotics and Infectious diseasesNorth AmericaPharmaceuticalResearchUSA

EU steps up its fight against drug-resistant bacteria

15-11-2013

A survey published by the European Commission today (November 15) reveals a decrease in antibiotic use…

Antibiotics and Infectious diseasesEuropeFinancialPharmaceuticalResearch

UK’s Helperby in deal with Cadila on ARB research and commercialization

14-11-2013

Privately-held Indian drugmaker Cadila Pharmaceuticals and UK based antibiotics discovery company, Helperby…

Antibiotics and Infectious diseasesAsia-PacificCadila PharmaceuticalsHelperby TherapeuticsMarkets & MarketingPharmaceuticalResearch

EMA publishes guidance on anti-bacterials targeted against MDR pathogens

EMA publishes guidance on anti-bacterials targeted against MDR pathogens

07-11-2013

The European Medicines Agency (EMA) has released an addendum to the guideline on the evaluation of medicinal…

Antibiotics and Infectious diseasesEuropeHealthcarePharmaceuticalRegulation

A*STAR and AstraZeneca link to combat Gram-negative bacterial infections

A*STAR and AstraZeneca link to combat Gram-negative bacterial infections

05-11-2013

Two units under Singapore’s Agency for Science, Technology and Research (A*STAR) have signed a joint…

A*STARAntibiotics and Infectious diseasesAstraZenecaPharmaceuticalResearch

Valneva updates on Phase II/III interim analysis of its Pseudomonas aeruginosa vaccine candidate

04-11-2013

Biotech firm Valneva has provided an update on the Phase II/III efficacy study interim analysis of its…

Antibiotics and Infectious diseasesBiotechnologyResearchValneva

Roche in-licenses POL7080 from Polyphor in up to 500 million-franc accord

Roche in-licenses POL7080 from Polyphor in up to 500 million-franc accord

04-11-2013

Drug major Roche has entered into an exclusive worldwide license agreement to develop and commercialize…

Antibiotics and Infectious diseasesLicensingPharmaceuticalPOL7080PolyphorRoche

176 to 185 of 468 results

Back to top